Comparison of acarbose and gliclazide as first-line agents in patients with type 2 diabetes

Salman S., Salman F., Satman I., Yilmaz Y., Ozer E., Sengul A., ...More

CURRENT MEDICAL RESEARCH AND OPINION, vol.16, no.4, pp.296-306, 2001 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 4
  • Publication Date: 2001
  • Doi Number: 10.1185/030079901750120231
  • Journal Name: CURRENT MEDICAL RESEARCH AND OPINION
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.296-306
  • Keywords: acarbose, gliclazide, type 2 diabetes mellitus, newly diagnosed, ALPHA-GLUCOSIDASE INHIBITORS, 24-WEEK MONOTHERAPY, NIDDM PATIENTS, EFFICACY, MELLITUS, PLACEBO, CARBOHYDRATE, METABOLISM, TOLERANCE, METFORMIN
  • Istanbul University Affiliated: Yes

Abstract

Aim: To compare the effect of acarbose and gliclazide on clinical findings, biochemical parameters and safety in type 2 diabetic patients insufficiently controlled with medical nutrition therapy (MNT).